Autor: |
Honig, Lawrence S., Sabbagh, Marwan N., van Dyck, Christopher H., Sperling, Reisa A., Hersch, Steven, Matta, Andre, Giorgi, Luigi, Gee, Michelle, Kanekiyo, Michio, Li, David, Purcell, Derk, Dhadda, Shobha, Irizarry, Michael, Kramer, Lynn |
Předmět: |
|
Zdroj: |
Alzheimer's Research & Therapy; 7/10/2024, Vol. 16 Issue 1, p1-4, 4p |
Abstrakt: |
This document is a correction notice for an article titled "Updated safety results from phase 3 lecanemab study in early Alzheimer's disease." The correction addresses typographical errors in the original article, including incorrect data in Table 2 and mislabeling of "ARIA-E" as "ARIA" in two places. The supplementary material has been updated to correct a participant's gender in Table S4. The document provides a table showing adverse events and ARIA in a clinical trial for lecanemab, as well as information on deaths in the study. The article has been updated, and the publisher remains neutral. The document also lists the names of several individuals mentioned by various authors. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|